Abiopharma

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds

PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer

Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin

ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology

Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats

PolyPid to Report Third Quarter 2025 Financial Results and Operational Highlights on November 12, 2025

Vistagen Appoints Paul Edick to its Board of Directors

Silo Pharma Selects Alphaledger’s T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain

Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

Johnson & Johnson announces first head-to-head study comparing IMAAVY™ with an alternative FcRn blocker in generalized myasthenia gravis (gMG) at AANEM Annual Meeting